ATE241366T1 - Zusammensetzungen von hyaluronat mit bimodalem molekulargewicht und verfahren zu deren verwendung - Google Patents

Zusammensetzungen von hyaluronat mit bimodalem molekulargewicht und verfahren zu deren verwendung

Info

Publication number: ATE241366T1
Authority: AT; Austria
Prior art keywords: molecular weight; compositions; bimodal molecular; trauma; alkaline earth
Prior art date: 1992-02-10

Application number

AT93905811T

Other languages

English (en)

Inventor

F Richard Christ

Original Assignee

Advanced Medical Optics Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1992-02-10

Filing date

1993-02-09

Publication date

2003-06-15

1993-02-09 Application filed by Advanced Medical Optics Inc filed Critical Advanced Medical Optics Inc

2003-06-15 Application granted granted Critical

2003-06-15 Publication of ATE241366T1 publication Critical patent/ATE241366T1/de

Links

229940014041 hyaluronate Drugs 0.000 title abstract 3
238000000034 method Methods 0.000 title abstract 3
239000000203 mixture Substances 0.000 title abstract 3
WCDDVEOXEIYWFB-VXORFPGASA-N (2s,3s,4r,5r,6r)-3-[(2s,3r,5s,6r)-3-acetamido-5-hydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4,5,6-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@@H]1C[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](C(O)=O)O[C@@H](O)[C@H](O)[C@H]1O WCDDVEOXEIYWFB-VXORFPGASA-N 0.000 title 1
230000002902 bimodal effect Effects 0.000 title 1
229910052783 alkali metal Inorganic materials 0.000 abstract 2
150000001340 alkali metals Chemical class 0.000 abstract 2
229910052784 alkaline earth metal Inorganic materials 0.000 abstract 2
-1 alkaline earth metal hyaluronate Chemical class 0.000 abstract 2
208000014674 injury Diseases 0.000 abstract 2
230000008733 trauma Effects 0.000 abstract 2
230000001681 protective effect Effects 0.000 abstract 1
238000001356 surgical procedure Methods 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Epidemiology (AREA)
Ophthalmology & Optometry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Molecular Biology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Polysaccharides And Polysaccharide Derivatives (AREA)

AT93905811T 1992-02-10 1993-02-09 Zusammensetzungen von hyaluronat mit bimodalem molekulargewicht und verfahren zu deren verwendung ATE241366T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US83297292A	1992-02-10	1992-02-10
PCT/US1993/001088 WO1993015744A1 (en)	1992-02-10	1993-02-09	Bimodal molecular weight hyaluronate formulations and methods for using same

Publications (1)

Publication Number	Publication Date
ATE241366T1 true ATE241366T1 (de)	2003-06-15

Family

ID=25263080

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT93905811T ATE241366T1 (de)	1992-02-10	1993-02-09	Zusammensetzungen von hyaluronat mit bimodalem molekulargewicht und verfahren zu deren verwendung

Country Status (8)

Country	Link
EP (1)	EP0625904B1 (de)
JP (1)	JP3751017B2 (de)
AT (1)	ATE241366T1 (de)
AU (1)	AU3658793A (de)
CA (1)	CA2129238A1 (de)
DE (1)	DE69333005T2 (de)
ES (1)	ES2199940T3 (de)
WO (1)	WO1993015744A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5492936A (en) *	1990-11-30	1996-02-20	Allergan, Inc.	Bimodal molecular weight hyaluronate formulations and methods for using same
AU2006287485B2 (en) *	2005-09-07	2012-07-12	Amo Regional Holdings	Bi-modal hyaluronate solution
CN101437527A (zh) *	2006-05-11	2009-05-20	桑德拉·戈博	透明质酸二元混合物及其治疗用途
WO2008000260A1 (en) *	2006-06-28	2008-01-03	Novozymes Biopolymer A/S	Compositions with several hyaluronic acid fractions for cosmetic and medical uses
WO2008003321A2 (en) *	2006-07-07	2008-01-10	Novozymes Biopolymer A/S	Compositions with several hyaluronic acid fractions for cosmetic use
US9539138B2 (en) *	2008-01-30	2017-01-10	Takaya TANAKA	Method of ophthalmic surgery and kit therefor
WO2010003797A1 (en) *	2008-07-09	2010-01-14	Novozymes Biopharma Dk A/S	Hyaluronic acid for corneal wound healing
FR2963240B1 (fr) *	2010-07-28	2013-03-15	Horus Pharma	Composition a usage topique sans conservateur comprenant de l'acide hyaluronique
EP2985027B1 (de)	2014-08-16	2021-03-31	Church & Dwight Co., Inc.	Nasenheilmittel enthaltend ein gemisch von hyaluronsäuren und salzlösung
EP2985019B1 (de)	2014-08-16	2021-10-20	Church & Dwight Co., Inc.	Nasale Zusammensetzung mit antiviralen Eigenschaften
WO2017119198A1 (ja) *	2016-01-05	2017-07-13	デンカ株式会社	半月板変性治療用組成物
KR20170090965A (ko) *	2016-01-29	2017-08-08	한미약품 주식회사	복합 히알루론산 가교물 및 그 제조방법
CA3119502C (en) *	2018-12-03	2024-06-18	Samuel Asculai	Pharmaceutical formulations and compositions suitable to treat mucositis
IT201900024208A1 (it) *	2019-12-17	2021-06-17	Altergon Sa	Miscele iniettabili di acido ialuronico per uso in dermoestetica

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4303676A (en) *	1980-03-21	1981-12-01	Balazs Endre A	Hyaluronate based compositions and cosmetic formulations containing same
IT1229075B (it) *	1985-04-05	1991-07-17	Fidia Farmaceutici	Medicamenti per uso topico, ottenuti tramite l'impiego dell'acido ialuronico
CH666897A5 (fr) *	1983-10-11	1988-08-31	Fidia Spa	Fractions d'acide hyaluronique non inflammatoire, procedes et compositions pharmaceutiques.

1993
- 1993-02-09 ES ES93905811T patent/ES2199940T3/es not_active Expired - Lifetime
- 1993-02-09 DE DE69333005T patent/DE69333005T2/de not_active Expired - Lifetime
- 1993-02-09 EP EP93905811A patent/EP0625904B1/de not_active Expired - Lifetime
- 1993-02-09 WO PCT/US1993/001088 patent/WO1993015744A1/en not_active Ceased
- 1993-02-09 AU AU36587/93A patent/AU3658793A/en not_active Abandoned
- 1993-02-09 AT AT93905811T patent/ATE241366T1/de not_active IP Right Cessation
- 1993-02-09 CA CA002129238A patent/CA2129238A1/en not_active Abandoned
- 1993-02-09 JP JP51422593A patent/JP3751017B2/ja not_active Expired - Lifetime

Also Published As

Publication number	Publication date
JP3751017B2 (ja)	2006-03-01
AU3658793A (en)	1993-09-03
ES2199940T3 (es)	2004-03-01
EP0625904B1 (de)	2003-05-28
CA2129238A1 (en)	1993-08-19
DE69333005D1 (de)	2003-07-03
WO1993015744A1 (en)	1993-08-19
DE69333005T2 (de)	2004-04-01
EP0625904A1 (de)	1994-11-30
JPH07503958A (ja)	1995-04-27

Similar Documents

Publication	Publication Date	Title
DE69333005D1 (de)	2003-07-03	Zusammensetzungen von hyaluronat mit bimodalem molekulargewicht und verfahren zu deren verwendung
WO1992017159A3 (en)	1993-01-07	Stabilized emulsion compositions for imparting an artificial tan to human skin
CA2186500A1 (en)	1995-10-05	Artificial tanning compositions having improved stability
DE59604165D1 (de)	2000-02-17	Substituierte Sulfonimidamide, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
HUT75089A (en)	1997-04-28	Compositions containing hyaluronic acid or it's derivatives and pharmaceutical active agent
DK224184D0 (da)	1984-05-04	Parenteralt praeparat af nimodipin,fremgangsmaade til dets fremstilling samt dets anvendelse ved bekaempelse af sygdomme
MX9203667A (es)	1992-07-31	Sales de bis-dimetoximetil (trimetoxibencil)quinolino, su preparacion y composicines farmaceuticas que las contienen.
DE58907085D1 (de)	1994-04-07	Glykosidase-Inhibitor Salbostatin, Verfahren zu seiner Herstellung und seine Verwendung.
AU541725B2 (en)	1985-01-17	Substituted 1,2,5-oxadiazole-2-oxides as pharmaceutical activ cpds,their use and medicaments containing them
EE04953B1 (et)	2008-02-15	Tsinkhaluronaadi kasutamine ja meetod ravimkoostise valmistamiseks
FI935825L (fi)	1994-06-29	2,4-substituoidut 5-(N-substituoitu-sulfamoyyli)-bentsoyyliguanidiinit, menetelmä niiden valmistamiseksi, niiden käyttö lääkeaineena tai diagnostisena aineena sekä niitä sisältävä lääkeaine
DE69420827D1 (de)	1999-10-28	Verfahren zur Herstellung von wässrigen Emulsionen zur Umhüllung von festen pharmazeutischen Zusammensetzungen
ATA56790A (de)	1991-10-15	Thieno-triazolo-diazepinderivate, verfahren zu deren herstellung und sie enthaltende therapeutische zusammensetzungen
DE59605782D1 (de)	2000-09-28	Substituierte Benzyloxycarbonylguanidine als Natrium-protonen Antiporter-Inhibitoren, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum, sowie sie enthaltendes Medikament
DE59702802D1 (de)	2001-02-01	Substituierte 2-Naphthoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
EP0801648A4 (de)	1998-01-28	Substituierte 2-arylcarbonyloxymethyl-1,2,5-thiadiazolidin-3-on-1,1-dioxid-derivate, sie enthaltende zusammensetzungen und verfahren zu ihrer verwendung
DE68913822D1 (de)	1994-04-21	Nichtvernetztes Hydrogel, Verfahren zu seiner Herstellung, seine Verwendung in der Medizin oder Chirurgie, insbesondere als Augenimplantat.
DE69434357D1 (de)	2005-06-09	Legierung auf Stahlbasis mit hohem Modul und Verfahren zu deren Herstellung
ATA86690A (de)	1994-09-15	2-substituierte n,n'-ditrimethoxybenzoylpiperazine, verfahren zu deren herstellung und sie enthaltende therapeutische zusammensetzungen
DE69423424D1 (de)	2000-04-20	Esculetinderivate, Verfahren zu deren Herstellung und deren Verwendung als pharmazeutische Zusammensetzungen
DE69215482D1 (de)	1997-01-09	2,2'-Alkylendiindolderivate, Verfahren zu ihrer Herstellung, sie enthaltende Arzneimittel und deren Verwendung als Ulcustherapeutikum
ATE82850T1 (de)	1992-12-15	Verwendung von 2-pyrimidinyl-1-piperazinderivaten.
SE9201425D0 (sv)	1992-05-06	Method and means for preventing constriction of the pupil in the eye
EP0743068A3 (de)	1998-06-03	Zusammensetzung zur Hemmung von Knochenverlust welche Vanadylsulfat enthält
HU9201267D0 (en)	1992-07-28	Method for producing pharmaceutical preparatives containing gfi

Legal Events

Date	Code	Title	Description
2003-11-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties